Question 1

What is LOPJLB’s current signal on SGMO?

Accepted Answer

LOPJLB’s latest quantitative signal on Sangamo Therapeutics, Inc. (SGMO) is SELL in a CRISIS regime. Signals are updated daily.

Question 2

What market regime is SGMO in?

Accepted Answer

Sangamo Therapeutics, Inc. (SGMO) is currently classified in the CRISIS HMM market regime on LOPJLB.

Question 3

What does Sangamo Therapeutics, Inc. (SGMO) do?

Accepted Answer

Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States. The company's clinical-stage product candidates are ST-920, a gene therapy product candidate, which is in Phase 1/2 clinical study for the treatment of Fabry disease; small fib…

Question 4

Where is Sangamo Therapeutics, Inc. based / listed?

Accepted Answer

Sangamo Therapeutics, Inc. is based in US, listed on OTC.

Sangamo Therapeutics, Inc. (SGMO)

Key stats

Industry peers

Prediction markets

Company news